Dysport® is indicated for:

  • focal spasticity, including the treatment of:
    • arm symptoms associated with focal spasticity in conjunction with physiotherapy;
    • and dynamic equinus foot deformity due to spasticity in ambulant paediatric cerebral palsy patients, two years of age or older, only in hospital specialist centres with appropriately trained personnel.
  • spasmodic torticollis in adults.
  • blepharospasm in adults.
  • hemifacial spasm in adults.


Dysport® is a white lyophilised powder for reconstitution.

Active substance

Clostridium botulinum type A toxin-haemagglutinin complex

Manufacturer by:  IPSEN BIOPHARM LTD. UK